After a five-month lapse, two of the most underutilized federal funding programs just got reauthorized and extended through 2031. If you’re building a technology-driven business and haven’t explored SBIR or STTR, now is a good time to look.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs;jointly branded as America’s Seed Fund, were reauthorized earlier this month when President Trump signed the legislation into law. The programs had been running without authorization since the end of federal fiscal year 2025 (September 30, 2025), creating uncertainty for both businesses and the agencies that fund them. That uncertainty is now resolved.
The scale of this opportunity
Since 1982, the programs have invested more than $81 billion into over 34,000 small businesses. Every participating federal agency, from the Department of Defense to the USDA to NASA, is required to set aside a specific percentage of its R&D budget for qualified small businesses. That translates to billions of dollars annually flowing to companies with fewer than 500 employees, distributed across three phases depending on how developed your technology is.
What changed in the new authorization
This isn’t a simple rubber-stamp renewal. The reauthorization came with meaningful updates that expand the upside for qualified businesses and add security guardrails the programs previously lacked.
- Higher investment ceilings. Phase award limits were increased across certain categories, giving businesses more runway per grant.
- A new “strategic breakthrough allocation.” Any agency with an SBIR set-aside of $100 million or more can now award up to $30 million to a single small business over a maximum of 48 months; provided the business has matching private funding and a market-validated technology. This is a significant development for later-stage deep tech companies that have already proven commercial traction.
- Mandatory security reviews. Applications from businesses with ties to foreign governments, militaries, or adversarial entities will now result in automatic denials — a long-overdue guardrail.
- Expanded agency participation. More agencies are now eligible to participate, widening the pool of available funding across sectors.
These programs have historically been strong fits for companies in defense tech, biotech, agtech, energy, and space; but they’re more accessible than most founders realize. If your business is doing real R&D, it’s worth understanding.
Other SBA changes worth knowing
A few other updates happened in parallel. Starting May 1, small manufacturers (NAICS sectors 31–33) became eligible for the SBA’s International Trade Loan Program at a 90% guarantee, versus the 75% guarantee available through the standard 7(a) program. That’s a meaningful difference if you’re financing export-related growth.
Fee waivers for small manufacturers also remain in place through September 30: 7(a) loans up to $950,000 carry a 0% upfront fee, and all 504 manufacturing loans carry 0% upfront and annual service fees. These aren’t permanent — the window matters.
The bottom line
SBIR and STTR are non-dilutive capital. No equity, no debt. If you’re doing genuine innovation work, you were likely going to spend that R&D budget anyway. The programs are competitive, but they’re less dilutive than almost anything else available at early stages.
The new authorization runs through September 2031. If you’re thinking about how non-dilutive capital fits into your broader financing strategy, that’s exactly the kind of conversation we have at Gazelle Ventures.